Dr Fricton received his BS and DDS degree from the University of Iowa (IA, USA), and then undertook his postgraduate studies, completing an MS in Oral Biology at UCLA School of Dentistry (University of California, CA, USA) and an Anesthesiology and Pain Management Residency at UCLA Medical Center. After research and clinical training at UCLA, he joined the faculty at the University of Minnesota (MN, USA), where he is currently a Professor in the Department of Diagnostic and Surgical Sciences and Physical Medicine and Rehabilitation. He is also a Senior Research Investigator at HealthPartners Research Foundation (MN, USA). He has over 30 years experience in clinical care, research and teaching in the field of chronic pain, orofacial pain, temporomandibular muscle and joint disorders, muscle pain, and, more recently, health informatics. His sponsored research has focused on epidemiological studies and clinical trials of therapeutic strategies for chronic pain conditions. He has developed a biobehavioral framework for personalized care for chronic pain conditions and has integrated this pain research with studies of health information technology, focusing on the use of electronic health records, personal health records and clinical decision support to improve the outcomes and quality of healthcare. He is Principal Investigator for the NIH NIDCR's temporomandibular joint (TMJ) Implant Registry and Repository, which includes research into the genetic, biomechanical and biobehavioral factors involved in the success or failure of TMJ implants. In addition, he has served on the governing board of the American Pain Society, and was president of both the American Board of Orofacial Pain and the American Academy of Orofacial Pain. He maintains an active private practice for patients with TMJ, orofacial, head and neck pain in Plymouth (MN, USA) and St Paul (MN, USA).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2217/pmt.11.9 | DOI Listing |
Sci Rep
December 2024
Department of Biophotonics Medicine, Nove de Julho University (UNINOVE), Rua Vergueiro, São Paulo, SP, 01525-000, Brazil.
This pragmatic double-blind randomized clinical trial aims to assess the impact of vascular photobiomodulation on post-COVID-19 patients experiencing tension-type headache, orofacial pain, or both persisting for more than 3 months. Participants were divided into two groups: vascular photobiomodulation (VPBM) and simulated VPBM. Their conditions were evaluated using the Brief Pain Inventory (BPI), Visual Analogue Scale, and Headache Impact Test (HIT-6).
View Article and Find Full Text PDFPLoS One
December 2024
Research Institute on Health Sciences (IUNICS-IdISBa), University of the Balearic Islands, Palma de Mallorca, Spain.
Background: Pain in people with cerebral palsy (CP) has been classically underestimated and poorly treated, particularly in individuals with impaired communication skills.
Objective: To analyze changes in different salivary metabolites and pain behavior scales after a painful procedure in adults with CP and adults with typical development.
Methods: Salivary levels of sTNF-α, sIgA, Cortisol, FRAP, ADA and Alpha Amylase, as well as 3 observational pain scales (Wong-Baker, Non-Communicating Adults Pain Checklist and Facial Action Coding System) were assessed before and after an intramuscular injection in 30 Individuals with CP and 30 healthy controls.
J Funct Biomater
December 2024
Division of Oral Surgery, Medical University of Gdańsk, 7 Dębinki Street, 80-211 Gdańsk, Poland.
Advanced platelet-rich fibrin (A-PRF) is produced by centrifuging the patient's blood in vacuum tubes for 14 min at 1500 rpm. The most important component of A-PRF is the platelets, which release growth factors from their ⍺-granules during the clotting process. This process is believed to be the main source of growth factors.
View Article and Find Full Text PDFJ Pers Med
December 2024
UWA Dental School, The University of Western Australia, Nedlands, WA 6009, Australia.
This study evaluated the accuracy of diagnosing oral and maxillofacial diseases using telehealth. We recruited 100 patients from the Oral Health Centre of Western Australia. They were either new patients or existing patients with a condition not previously diagnosed.
View Article and Find Full Text PDFClin Pract
November 2024
Institute for Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, 37007 Salamanca, Spain.
Background/objectives: Temporomandibular disorders affect the muscles used for chewing, the temporomandibular joint, and other related tissues, resulting in pain, limited mobility, and dysfunction of the masticatory muscles. Physical therapy plays a critical role in treatment. Manual therapy can trigger neurophysiological mechanisms that contribute to pain relief and a reduction in muscle activation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!